Abstract
DNA alkylation: The reactivity and selectivity of DNA-alkylating duocarmycin analogues were determined by direct ESI-FTICRMS (negative-ion mode) measurements. The high efficiency of a new seco drug for the alkylation of duplex DNA has been determined in this way for the first time (picture: drug bound covalently to an oligodeoxynucleotide). The corresponding, less toxic prodrug and the enantiomer of the seco drug show, in contrast, only a very low alkylation tendency.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
